Published on
A new nasal formulation of the flu vaccine has been approved for at-home administration for individuals 2 through 49 years of age, according to an announcement from the Food and Drug Administration (FDA). The vaccine will still require a prescription, and it won’t be available until next year. Patients can order FluMist nasal spray directly from an online pharmacy. Those who choose the online option will be screened with an eligibility assessment, and if appropriate, will receive a prescription and home delivery of the self-administered vaccine.
Still available in urgent care: FluMist was initially approved by FDA in 2003, and it can still be administered in a provider’s office or pharmacy.
FDA Approves FluMist For At-Home Use